Cancer Discovery 收藏杂志
  • 中科院分区:1区
  • JCR分区:Q1
  • CiteScore :26.9

Cancer Discovery

SCI SCIE
国际简称:CANCER DISCOV 中文名称:癌症发现

Cancer Discovery杂志是一本ONCOLOGY应用杂志。是一本享有盛誉的顶级学术杂志,由American Association for Cancer Research Inc.出版,该期刊创刊于2011年,出版周期为12 issues/year,始终保持着高质量和高水平的学术内容。在中科院分区表《新锐期刊分区表》中,被归类为大类学科分区1区,显示出其卓越的学术水平和影响力。

  • ISSN:2159-8274

  • 出版地区:UNITED STATES

  • 出版周期:12 issues/year

  • E-ISSN:2159-8290

  • 创刊时间:2011

  • 出版语言:English

  • 是否OA:未开放

  • 预计审稿时间:较慢,6-12周

  • 影响因子:29.5

  • 是否预警:否

  • 研究方向:ONCOLOGY

  • 年发文量:120

  • 研究类文章占比:89.17%

  • Gold OA文章占比:51.29%

  • H-index:119

  • 出版国人文章占比:0.04

  • 开源占比:0.2424

  • 文章自引率:0.0141...

杂志简介

《癌症发现》发表具有高影响力的同行评议文章,介绍研究和临床试验的重大进展。作为首屈一指的癌症信息资源,该期刊还向读者提供评论文章、观点和评论、新闻报道和重要期刊文章的研究观察摘要,让他们了解该领域的最新发现。主题涵盖癌症研究和医学的各个领域,从实验室到临床和流行病学研究

值得一提的是,Cancer Discovery已成功入选SCI(科学引文索引) 、 SCIE(科学引文索引扩展版) 等国际知名数据库,这进一步彰显了其作为国际优秀期刊的卓越地位和广泛影响力。自创刊以来,该杂志一直保持着12 issues/year的出版周期,以高质量、高水平的学术内容著称。在JCR(Journal Citation Reports)分区等级中,该期刊荣获Q1评级。此外,其CiteScore指数达到26.9,该期刊2026年的影响因子达到29.5,再次验证了其优秀学术水平。

Cancer Discovery是一本未开放获取期刊,但其高质量的学术内容和广泛的影响力使其成为了医学-肿瘤学研究领域不可或缺的重要刊物。无论是对于学者、研究人员还是学术界来说,该期刊都是一份不可或缺的重要资源。

期刊指数

中科院SCI分区
CiteScore指数
自引率
发文量
影响因子

中科院SCI分区是中国科学院对SCI期刊进行的一种分类和评级。在学术界,中科院SCI分区被广泛应用于科研业绩奖励、职称评审等方面。许多高校和科研单位会按照中科院SCI分区的标准来加权计算科研成果的影响力。因此,对于科研工作者来说,了解中科院SCI分区的标准和方法,以及具体的分区结果,对于评估自己的科研成果和选择合适的期刊发表论文都非常重要。

CiteScore(或称为引用指数)是由全球著名学术出版商Elsevier于2016年12月基于Scopus数据源推出的期刊评价指标。CiteScore指数能够反映期刊在较长时间内的平均影响力。通过计算期刊过去四年内发表的文章被引用的次数,这使得该指标能够更准确地评估期刊的影响力和学术价值。

自引率的计算公式为:自引率 = (期刊自己发表的文章被自己引用的次数) / (期刊自己发表的文章总数)。其中,期刊自己发表的文章指的是该期刊所发表的所有论文,包括文章、综述、简报、通讯等各类论文。如果自引率过高,可能会影响到该期刊的学术声誉和权威性。

中科院分区表

《新锐期刊分区表》 2026年3月发布

Top期刊 综述期刊 大类学科 小类学科
是 否 医学 1区
ONCOLOGY 肿瘤学
1区

期刊分区表 2025年3月升级版

Top期刊 综述期刊 大类学科 小类学科
是 否 医学 1区
ONCOLOGY 肿瘤学
1区

JCR 分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 10 / 333

97.1

学科:ONCOLOGY SCIE Q1 8 / 333

97.75

CiteScore 分区(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
26.9 7.389 4.307
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 16 / 428

96%

文章摘录

  • Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogrammin Author: Ji, Yiyi; Ju, Cheng-Wei; Chen, Lei; Shen, Kai; Su, Ruopeng; Li, Ang; Liu, Xinyu; Liu, Bo; Zhang, Xinran; Lyu, Ruitu; Xia, Peng; Li, Han; Pan, Yiqian; Liu, Yunzheng; Tse, Man Hin; Xue, Yizheng; Qian, Hongyang; Jing, Na; Zhu, Helen He; Wang, Liangliang; Zhang, Li-Sheng; Jiang, Shu-Heng; Zhang, Weiwei; Dong, Liang; Yan, Zejun; Pan, Jiahua; Zhu, Yinjie; Wei, Jiangbo; Wang, Qi; Xue, Wei Journal: CANCER DISCOVERY. 2026; Vol. 16, Issue 4, pp. 760-780. DOI: 10.1158/2159-8290.CD-25-0974
  • p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therap Author: Zhou, Lin; DeMarco, Kelly D.; Murphy, Katherine C.; Wu, Zhenpeng; Li, Jinping; Johnson, Calvin; Liu, Bin; Giwa, Hadiya K.; Ma, Boyang; Bhalerao, Nikita; Li, Junhui; Jiang, Zhong; Bai, Shi; Parikh, Chaitanya N.; Ye, Tianyi; Simin, Karl; Zhu, Lihua J.; Pitarresi, Jason R.; Wu, Hong; Ruscetti, Marcus Journal: CANCER DISCOVERY. 2026; Vol. 16, Issue 3, pp. 571-591. DOI: 10.1158/2159-8290.CD-25-1212
  • A Prognostic Signature for Lung Adenocarcinoma in Patients Who Have Never Smoke Author: Zhao, Wei; Zhang, Tongwu; Hua, Xing; Hoang, Phuc H.; Miraftab, Mona; Saha, Monjoy; Mcelderry, John P.; Sang, Jian; Lee, Olivia W.; Hartman, Caleb; Khandekar, Azhar; Sharma, Sunandini; Colon-Matos, Frank J.; Anyaso-Samuel, Samuel; Wang, Difei; Jones, Kristine; Hutchinson, Amy; Hicks, Belynda; Rosenbaum, Jennifer; Zhong, Xiaoming; Yang, Yang; Pesatori, Angela C.; Consonni, Dario; Christiani, David C.; Leung, Kin Chung; Wong, Maria Pik; Manczuk, Marta; Lissowska, Jolanta; Swiatkowska, Beata; Mukeria, Anush; Shangina, Oxana; Zaridze, David; Holcatova, Ivana; Mates, Dana; Milosavljevic, Sasa; Ognjanovic, Simona; Savic, Milan; Kontic, Milica; Gaborieau, Valerie; Brennan, Paul; Arrieta, Oscar; Bosse, Yohan; Edell, Eric S.; Schabath, Matthew B.; Hofman, Paul; Mas, Luis; Yendamuri, Sai S.; Chen, Chih-Yi; Chang, I-Shou; Hsiung, Chao Agnes; Liu, Geoffrey; Martinez Santamaria, Jacobo; Gould Rothberg, Bonnie E.; Mutreja, Karun; Lawrence, Scott; Rothman, Nathaniel; Alexandrov, Ludmil B.; Leduc, Charles; Baine, Marina K.; Joubert, Philippe; Sholl, Lynette M.; Travis, William D.; Homer, Robert; Lan, Qing; Chanock, Stephen J.; Yang, Lixing; Yang, Soo-Ryum; Shi, Jianxin; Landi, Maria Teresa Journal: CANCER DISCOVERY. 2026; Vol. 16, Issue 3, pp. 460-477. DOI: 10.1158/2159-8290.CD-25-0581
  • Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cance Author: Xu, Qin; Deng, Zhengrong; Liu, Jing; Zhuo, Yanhong; Zhu, Fei; Chang, Lele; Liu, Qin; Fu, Yajuan; Li, Peiwei; Liu, Yunyun; Huang, Songhua; Li, Li; Xie, Xingyun; Chen, Ying; Lin, Yingtao; Zang, Lele; Ke, Meifang; Chen, Li; Huang, Xiaoxia; Wang, Cong; Wang, Yanhong; Kang, Yaxin; Wang, Yuqin; Zhu, Mingxuan; Zhang, Huiqi; Wang, Zhixin; Zhang, Peidong; Hu, Dan; Lu, Huaiwu; Sun, Yang; Zhou, Shengtao Journal: CANCER DISCOVERY. 2026; Vol. 16, Issue 3, pp. 439-459. DOI: 10.1158/2159-8290.CD-25-1315
  • PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesi Author: Tang, Shuang; Zhou, Qian; Bergholz, Johann S.; Jiang, Tao; Wang, Weihua; Ji, Renlei; Huang, Wendi; Wu, Jiachen; Li, Yutong; Wan, Xiaochun; He, Xiadi; Jing, Qianchen; Sun, Menghong; Johnson, Jared L.; Yaron-Barir, Tomer M.; Li, Da-Qiang; Dai, Bo; Wang, Zefeng; Li, Xiaoling; Cantley, Lewis C.; Roberts, Thomas M.; Zhao, Jean J Journal: CANCER DISCOVERY. 2026; Vol. 16, Issue 3, pp. 521-540. DOI: 10.1158/2159-8290.CD-25-1126
  • Mutational Signatures and Clonal Hematopoiesis in Intestinal Metaplasia across Countries with Varying Stomach Cancer Incidenc Author: Huang, Kie Kyon; Hagihara, Takeshi; Lian, Benedict Shi Xiang; Ong, Zhi Xuan; Lim, Shen Kiat; Chong, Roxanne Hui Heng; Srivastava, Supriya; Kang, Jason Xing; Lee, May Yin; Tan, Angie Lay-Keng; Lee, Minghui; Ho, Shamaine Wei Ting; Binte Abdul Ghani, Siti Aishah; Ng, Clara Shi Ya; Liang, Ruanyi; Liu, Lin; Tay, Su Ting; Ong, Xuewen; Zhu, Feng; Chen, Hui; Li, Zhen; Ang, Tiing Leong; Gotoda, Takuji; Huang, Robert J.; Khor, Christopher J. L.; Kim, Hyun-Soo; Lau, Louis Ho Shing; Lee, Yi-Chia; Takasu, Ayaka; Teh, Ming; Thian, Mann Yie; Tam, Wai Leong; Lu, Xin; Wong, Sunny H.; So, Jimmy B. Y.; Chung, Hyunsoo; Lee, Jonathan; Yeoh, Khay Guan; Tan, Patrick; Singapore Gastric Cancer Consortium Journal: CANCER DISCOVERY. 2026; Vol. 16, Issue 3, pp. 497-520. DOI: 10.1158/2159-8290.CD-25-0778
  • Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Bindin Author: Chen, Wanyi; Gupta, Avantika; Mai, Nicholas; Nag, Sharanya; Lau, Joshua S.; Singh, Sukrit; Chodera, John D.; Liu, Bo; de Stanchina, Elisa; Pareja, Fresia; Hashmi, Atif Ali; Lieberman, Miriam M.; Modi, Shanu; Bromberg, Jacqueline; Razavi, Pedram; Drago, Joshua Z.; Chandarlapaty, Sarat Journal: CANCER DISCOVERY. 2026; Vol. 16, Issue 2, pp. 235-249. DOI: 10.1158/2159-8290.CD-25-0647
  • Activation of T Cell-Intrinsic p53 by Acetylation Elicits Antitumor Immunity to Boost Cancer Immunotherap Author: Yan, Xiaojun; Xu, Wenbin; Yao, Han; Wu, Zhen; Ning, Jingyuan; Zhao, Shidong; Liu, Yajing; Zhang, Meng; Xu, Dongkui; Shen, Zhanlong; Gu, Wei; Wang, Donglai Journal: CANCER DISCOVERY. 2026; Vol. 16, Issue 1, pp. 155-176. DOI: 10.1158/2159-8290.CD-25-0649

免责声明

若用户需要出版服务,请联系出版商:615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404。